A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST)

Giovanni Cappello,Valentina Giannini,Roberto Cannella,Emanuele Tabone,Ilaria Ambrosini, Francesca Molea,Nicolò Damiani, Ilenia Landolfi,Giovanni Serra,Giorgia Porrello,Cecilia Gozzo,Lorena Incorvaia,Giuseppe Badalamenti,Giovanni Grignani,Alessandra Merlini,Lorenzo D’Ambrosio,Tommaso Vincenzo Bartolotta,Daniele Regge

European Journal of Radiology Open（2023）

引用 0|浏览16

暂无评分

摘要

•Only GIST with specific genotypes are sensitive to imatinib.•Radiomics helps to correlate pre-treatment CT features to GIST mutational status, predicting response to imatinib treatment.•The developed radiomics signature improve treatment allocation, accuracy and appropriateness.

查看译文

关键词

Artificial intelligence, Radiomics, GIST, Mutational status, Response to therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要